Neutral
Salesforce's stock drops 2% to $245 despite analysts raising price targets
Despite positive analyst reactions to Salesforce's recent Dreamforce event, the company's stock declined by 2% to $245. Analysts raised price targets, citing the company's growing AI initiatives and strategic partnerships. However, the stock's performance suggests that investors are cautious about the company's valuation and market conditions.
Key points
- Analysts, including Stifel, Canaccord Genuity, and Guggenheim, raised their price targets to $300, citing Salesforce's expanding AI business and potential for higher valuation.
- UBS maintained a Neutral rating with a $240 price target, focusing on the Claudeforce partnership and its integration with Anthropic's models.
- Despite positive analyst coverage, the stock's 2% decline to $245 indicates investor caution regarding valuation and broader market conditions.
Sources
- CRM Stock Drops Despite Fresh Price Target Hikes – JPMorgan Believes Investor Day Was 'Incrementally Positive’ For Re-Rating ThesisYahoo Finance · September 17, 2026
- Salesforce stock holds at Neutral as UBS keeps $240 target ahead of eventInvesting.com · September 11, 2026
- Salesforce (CRM) Stock Price & OverviewStockAnalysis.com · September 19, 2026
AI-generated from public news sources. Not financial advice.
